Clinical Trial Update: Hypothermia Enhanced by Magnesium Sulphate [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating hypothermia enhanced with magnesium sulfate for hypoxic-ischemic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Polish Mother Memorial Hospital Research Institute | Conditions: Perinatal Anoxic-ischemic Brain Injury | Phase 2, Phase 3 | Status: COMPLETED